Testing arbidol for allergic rhinitis
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if arbidol, an antiviral medicine, can safely treat allergic rhinitis (hay fever). It might help if your nasal symptoms like sneezing or stuffiness are moderate to severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with allergic rhinitis (hay fever).
- You have at least 2 nasal symptoms like sneezing or runny nose, and they are moderate or worse.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
- You haven't been in another clinical trial in the last 3 months.
- You are willing to follow the study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two combination treatments for moderate to severe allergic rhinitis (hay fever). One group uses a corticosteroid nasal spray plus an antihistamine nasal spray, and the other uses the same spray plus an oral antihistamine pill. The goal is to see which combination better improves symptoms like sneezing, runny nose, and congestion.
This study tests whether a specific type of acupuncture can reduce allergy symptoms like sneezing, runny nose, and nasal congestion. It may offer an alternative for people whose symptoms are not well controlled by standard treatments.
This study tests whether taking a combination of probiotics (good bacteria) and vitamin D can help reduce hay fever symptoms. It may be a good option if your vitamin D is low and you haven't used probiotics recently.
This trial studies whether a yeast-based supplement can help manage ongoing allergic rhinitis (nasal allergy) symptoms like sneezing, runny nose, and itching. It's for people aged 18-35 who have symptoms most days for at least 4 weeks.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.